5-ETHYL-IMIDAZO (5,1-F) (1,2,4,) TRIAZIN-4 (3H) -ONES AS PHOSPHODIESTERASE INHIBITORS

Details for Australian Patent Application No. 2003224113 (hide)

Owner BAYER AKTIENGESELLSCHAFT

Inventors NIEWOHNER, Ulrich; ALONSO-ALIJA, Cristina; GIELEN, Heike; MICHELS, Martin; SCHAUss, Dagmar; BISCHOFF, Hilmar; BURKHARDT, Nils; GEISS, Volker; SCHLEMMER, KarlHeinz; CUTHBERT, Nigel; FITZGERALD, Mary, F.; STURTON, Graham

Pub. Number AU-A-2003224113

PCT Number PCT/EP03/04140

PCT Pub. Number WO2003/093270

Priority 0209989.3 01.05.02 GB

Filing date 22 April 2003

Wipo publication date 17 November 2003

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 031/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 011/06 Drugs for disorders of the respiratory system

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0209989.3 01.05.02 GB

8 January 2004 Application Open to Public Inspection

  Published as AU-A-2003224113

20 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224114-CENTRIFUGE COMPRISING HYDRAULIC DIFFERENTIAL SPEED DETERMINATION

2003224112-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 7 (LGR7)